Congestive cardiac failure occurs when the myocardium fails to pump blood effectively to meet the metabolic demands of the body. This structural or functional impairment leads to fluid retention, elevated intracardiac pressures, and hallmark symptoms like dyspnea, fatigue, and peripheral edema. Pharmacological management focuses on interrupting the neurohormonal pathways that worsen cardiac remodeling and reduce overall mortality. Treatment strategies also prioritize symptom relief, preventing hospital readmissions, and improving functional capacity. Nurses play a frontline role in evaluating therapeutic responses and identifying early signs of hemodynamic decompensation.
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers interrupt the renin-angiotensin-aldosterone system. By blocking the conversion or receptors of angiotensin II, these agents promote vasodilation and lower systemic vascular resistance. This reduction in afterload decreases the workload on the failing left ventricle.
Serum potassium and renal function must be monitored regularly during therapy, as these drugs can induce hyperkalemia and acute kidney injury.
Beta-blockers counteract the damaging effects of chronic sympathetic nervous system overactivation in heart failure. Although they depress myocardial contractility initially, long-term administration improves left ventricular ejection fraction and reduces sudden cardiac death.
Treatment must be initiated at very low doses and titrated upward slowly. Rapid initiation can precipitate acute decompensation.
Diuretics relieve the fluid overload symptoms of congestive cardiac failure by enhancing renal excretion of water and sodium.
| Diuretic Class | Primary Site of Action | Clinical Example | |
|---|---|---|---|
| --- | --- | --- | > |
| Loop | Ascending limb of Loop of Henle | Furosemide | |
| Thiazide | Distal convoluted tubule | Hydrochlorothiazide | |
| Potassium-Sparing | Collecting duct | Spironolactone |
Loop diuretics are the mainstay for rapid fluid removal in acute congestion. Potassium-sparing agents like spironolactone provide mild diuresis while blocking aldosterone receptors to prevent myocardial fibrosis. Nurses must monitor daily weights, strict fluid intake and output, and serum electrolyte panels to catch hypokalemia or hyperkalemia early.
Digoxin exerts a positive inotropic effect by inhibiting the sodium-potassium adenosine triphosphatase pump in myocardial cells. This inhibition increases intracellular calcium, enhancing myocardial contractility and stroke volume. Additionally, digoxin reduces sympathetic outflow and slows conduction through the atrioventricular node, making it useful in heart failure complicated by atrial fibrillation.
Digoxin has a very narrow therapeutic index. Toxicity is common and dangerous, presenting with nausea, vomiting, visual disturbances like yellow-green halos, and severe cardiac dysrhythmias. Hypokalemia increases the risk of toxicity because potassium competes with digoxin for binding sites on the enzyme pump.
Patients presenting with acute decompensated heart failure and severe congestion often require intravenous therapies in high-dependency units. Intravenous vasodilators like nitroglycerin or nitroprusside rapidly reduce preload and afterload by relaxing vascular smooth muscle. Inotropic agents such as dobutamine or milrinone stimulate myocardial contractility when cardiac output remains critically low despite diuretic therapy. These potent drugs require continuous hemodynamic monitoring via arterial lines or central venous catheters because of the high risk of severe hypotension and lethal arrhythmias.
Managing heart failure in resource-constrained Nigerian settings requires vigilant clinical assessment and practical patient education. Nurses must educate patients on daily self-monitoring, emphasizing daily weight checks to catch fluid retention before severe pulmonary edema occurs. Dietary counseling must address salt reduction while respecting local culinary traditions. Medication adherence is frequently challenged by out-of-pocket drug costs and the proliferation of fake or substandard pharmaceutical products. Nurses must counsel patients to procure medications only from accredited pharmacies, check expiry dates meticulously, and report early signs of adverse drug reactions or toxicity.